Agenda – 10th KOL/Thought Leader Engagement and Advisory Boards Summit

  • DAY ONE
  • DAY TWO

DAY ONE

 TUESDAY, JUNE 18

8:45 – 9:00

Chairperson's Opening Remarks
Howard Berkowitz, Respiratory and Immunology Medical Science Liaison – US Field-Based Medical Affairs N. NJ /NYC Region, Sanofi

9:00 – 9:45

The Time Lapse of KOL Identification in the Evolving Healthcare Industry
Robert Geller, Vice President, Medical Affairs, HERON THERAPEUTICS

9:45 – 10:30

KOL Engagement: The Before, During and After
Trina Stonner, RN, MSN, President, AVANT HEALTHCARE

10:30 – 11:00

Networking Break

11:00 – 12:00

Coordinating Aligned Communications With KOLs
Bob Numerof, VP Medical Affairs, RIGEL PHARMACEUTICALS

12:00 – 1:00

Luncheon

1:00 – 1:45

Tomorrow’s Medical Today: Effectively Engaging Key Thought Leaders — 2020 and Beyond
William Soliman, President, Chairman of the Board, ACMA

2:30 – 3:00

Networking Break

3:00 – 3:45

MSL As the Valued and Credible Asset to the Payer and Provider Community — Develop and Maintain Relationships With KOLs
Howard Berkowitz, Respiratory and Immunology, MSL, U.S. Field-Based Medical Affairs, SANOFI GENZYME

3:45 – 4:15

Enhance Commercial KOL Engagement
Christopher Alfieri, Thought Leader Liaison, EMD SERONO


DAY TWO

 WEDNESDAY, JUNE 19

8:45 – 9:00

Chairperson's Recap of Day One
Howard Berkowitz, Respiratory and Immunology Medical Science Liaison – US Field-Based Medical Affairs N. NJ /NYC Region, Sanofi

9:00 – 9:45

Keeping KOLs Engaged During Prolonged Product Development
Joseph Chiodo, Senior Medical Director, AGILE THERAPEUTICS

9:45 – 10:30

Engage KOLs From the Medical Device Perspective
Grant Freidrich, KOL/Relationships Manager, DENTSPLY WELLSPECT HEALTHCARE

10:30 – 11:00

Networking Break

11:00 – 11:45

Medical Affairs and Thought Leader Perspectives on Successful Advisory Board Execution
Daniel Jones, Senior Medical Director, EMD SERONO

11:45 – 12:30

Understanding the Clinical Trails Perspective and KOL Development
Deanine Halliman, Director, North American Medical Affairs, ELEKTA

12:30 – 1:30

Luncheon

1:30 – 2:15

Bridge the Gap Between Clinical Development and Medical Affairs in Comparison to Big and Small Pharma Companies
Brandi Howard, Senior Vice President, Global Clinical Development and Medical Affairs, EVOFEM BIOSCIENCES

2:15 – 2:45

Setting up for Success When Hiring MSLs
Bryan Bischel, Executive Director, Medical Affairs, NOTAL VISION

2:45 – 3:30

KOL Engagement Through an Academic Cardiologist’s Standpoint
Peter Kowey, M.D., FACC, FHRS, FAHA, Professor of Medicine and Clinical Pharmacology, JEFFERSON MEDICAL COLLEGE; The William Wikoff Smith Chair in Cardiovascular Research, LANKENAU HOSPITAL AND MEDICAL RESEARCH CENTER

3:30 – 4:00

Networking Break

4:00 – 4:45

PANEL: Small Pharma Vs. Big Pharma: Keeping KOLs Engaged
Joseph Chiodo, Senior Medical Director, AGILE THERAPEUTICS